
FAO Calls For Action Amid Foot-And-Mouth Disease Outbreaks
5 May 2025
FMD is a highly contagious viral disease affecting cloven-hoofed animals, including cattle, pigs, sheep, goats, and various wild species.
Europe is currently facing its worst outbreak so far this century at the same time as an exotic viral strain has been introduced in Iraq and other countries in the Near East.
Concern for potential spread
' FAO is recommending urgent biosecurity measures and enhanced surveillance following the recent detection of foot-and-mouth disease (FMD) serotype SAT1 in Iraq and Bahrain,' the agency said in analert.
'This serotype is exotic to the Near East and West Eurasia regions,' the agency continued – meaning the strain is not normally found there – which raises 'serious concerns' about its potential spread.
FMD is typically characterized by fever and blisters in the mouth and on the feet of affected livestock, accompanied by lameness. Although few adult animals succumb to disease, young ones may die from sudden heart failure.
The virus spreads rapidly and can affect large numbers of animals, especially in countries or regions that are usually free of the disease or do not regularly use vaccination.
Although FMD is not a public health threat, it severely impacts animal health and welfare, food security and incomes by reducing agricultural productivity, including through decreased milk and meat yields.
The economic impact is also substantial, with global direct production losses and vaccination costs in endemic regions estimated to be $21 billion annually. FAO noted that the true economic burden is likely much higher when disruptions to both international and local trade are taken into consideration.
A major outbreak in the United Kingdom in 2001 led to the culling of more than six million animals and cost the economy billions, devastating the livestock industry and tourism. A series of new measures in response have reportedly reduced the risk and improved resilience, including local and national contingency plans for outbreaks.
Outbreaks and response
The FMD virus was recently detected in parts of Europe normally free of the disease and the continent is now experiencing its worst outbreak since 2001.
Germany detected an outbreak this past January but has since been declared FMD-free, however subsequent outbreaks in Hungary and Slovakia have persisted.
In response, the UK recently announced that it has banned imports of meat or dairy products from European countries where the virus has been detected, as well as Austria due to the outbreak in neighbouring Hungary.
FMD is endemic in the Near East, but the recent upsurge is due to an exotic serotype likely introduced from East Africa. Cases have been reported in Bahrain, Iraq and Kuwait, although other countries are at high risk.
Many strains of the FMD virus continue to circulate in different parts of the world, and the recent outbreaks in both Europe and the Near East highlight the ongoing risk the disease poses to livelihoods, food security and safe trade, said FAO.
Raising awareness
While all governments are urged to be vigilant, the agency said affected and high-risk countries should consider awareness-raising measures among farmers and communities to protect livestock.
Other recommendations include biosecurity measures such as separating sick animals from other livestock and having them examined by professionals, alongside checking vaccination records and verifying FMD contingency plans.
FAO said that by implementing these measures, countries can significantly reduce risks.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Otago Daily Times
10 hours ago
- Otago Daily Times
Discovery of genes relevant to disease a ‘eureka moment'
University of Otago microbiologist and immunologist Dr Tony Merriman. PHOTO: SUPPLIED Treatment for calcium pyrophosphate deposition (CPPD) disease — more commonly known as inflammatory arthritis — may soon take a major step forward following a major discovery by a University of Otago researcher. There is an unmet need for treatment of CPPD disease, which focuses on the alleviation of inflammation with non-steroidal anti-inflammatory drugs. But University of Otago microbiologist and immunologist Dr Tony Merriman has led an analysis of the genes of 550,000 Americans with the disease, while based at the University of Alabama, Birmingham. It is a first-of-its-kind genome-wide association study into the disease and the research found two genes — RNF144B and ENPP1 — that cause the debilitating calcium pyrophosphate crystal deposits in joints. He said the genes were detected both in people of European ancestry and African ancestry. "The most significant result of our research was the discovery of one of the genes, ENPP1. "The protein encoded by this gene controls the production of chemicals — adenosine monophosphate and inorganic pyrophosphate — that, together with calcium ions, lead to the formation of the CPP crystals," Dr Merriman said. Little is known about the other gene — RNF144B — aside from the possibility it is involved in inflammation. More was known about ENPP1 and of its potential importance to people with CPPD disease. Drugs targeting the protein have been developed in the treatment of infectious disease and cancer and they could now be evaluated for the treatment of CPPD disease. Dr Merriman said the discovery opened up promising new avenues for targeted prevention and treatment of CPPD disease, which were lacking at present. Co-investigator and Brigham and Women's Hospital rheumatology, inflammation and immunity division researcher Dr Sara Tedeschi said the genome-wide association with ENPP1 was "particularly exciting" as a rheumatologist because "it makes sense". "ENPP1 generates inorganic pyrophosphate, one of the components of CPP crystals. "Patients with CPPD disease are desperate for an effective treatment and trials testing ENPP1 inhibitors in CPPD disease would be of great interest." Dr Merriman said the researchers were "thrilled" about the potential impact of their discovery and the possibility of new drugs being developed for the treatment of CPPD disease. "The findings of this study produced a 'eureka moment', which can be rare in a scientist's career."


Scoop
3 days ago
- Scoop
In Gaza, Daily Food Intake Has Fallen Well Below ‘Survival' Level
5 June 2025 Latest data simulations from the Food and Agriculture Organization (FAO) point to the average Gazan eating just 1,400 calories per day – 'or 67 per cent of what a human body needs to survive" (2,300 calories) as of May. Between October 2023 and the end of December 2024, average intake was 1,510 calories per day, or 72 per cent of the minimum recommended amount. 'The findings reveal systemic and escalating violations of both international human rights law and international humanitarian law, particularly concerning the right to adequate food, the prohibition of starvation as a method of warfare, and the protection of civilians in armed conflict,' FAO insisted. Even based on its most optimistic food availability scenario, the UN agency estimated that energy intake was just 1,470 calories per person per day on 11 May, during the complete aid blockade imposed by Israel, beginning 2 March. ' This has critical implications for hunger and undernutrition, especially for families without cash and/or able-bodied men, as well as children, pregnant and lactating women, person with disabilities and the elderly,' FAO explained. The agency noted that its analysis is in line with dire warnings of acute hunger across Gaza issued by UN-backed food security experts last month, based on the lack of available wheat flour, pulses, rice, dairy products, and vegetable oil. Without an improvement in the amount of aid being allowed into Gaza for distribution by established agencies, FAO warned that the already dire humanitarian situation could deteriorate even further. This is despite repeated calls to Israel from the United Nations including from the Secretary-General to allow more aid in at scale, in line with 'binding orders' issued by the International Court of Justice to fully cooperate with the UN and ensure that aid reaches the people of Gaza without delay. Unknown number of dead Gaza's population today is approximately 2.1 million, down from 2.23 million in October 2023 before the war began following Hamas-led terror attacks in Israel. Citing the Palestinian authorities, FAO said that as of 30 April, 52,400 Palestinians had been reported killed, while another 11,000 were feared missing, presumably under the rubble. While more than 60,000 children have been born in the Gaza Strip during the conflict, 'an unknown number of Palestinians have died of natural causes or indirectly from the conflict, due to hunger, untreated diseases or injuries since October 2023', FAO said. The UN agency also referred to a June 2024 article by the authoritative medical journal The Lancet suggesting that up to 186,000 people would likely die from indirect causes because of the conflict, at a 'conservative' rate of four indirect deaths for every direct death. According to FAO's simulation, 2,297 tonnes - equivalent to 120 trucks - per day are required to deliver food baskets providing 2,100 calories per person per day to the entire population of the Gaza Strip. On Wednesday, UN teams requested access for 130 truckloads of aid via Kerem Shalom, but only 50 carrying flour were approved to enter from Israel.


Scoop
7 days ago
- Scoop
Why Is The New Zealand Media Not Questioning The Implications Of The Gene Technology Bill?
Press Release – Lisa Er Despite the profound ethical, environmental, and societal implications, there has been a noticeable lack of critical scrutiny from the mainstream media, says Lisa Er. As the Gene Technology Bill advances through Parliament, New Zealand faces a pivotal moment in science, agriculture, and public health. The proposed legislation would significantly relax restrictions on gene technology, enabling broader research, development, and use of genetically modified organisms (GMOs) in New Zealand for the first time in nearly 30 years Yet, despite the profound ethical, environmental, and societal implications, there has been a noticeable lack of critical scrutiny from the mainstream media. 'It is plausible that political and economic factors are influencing the nature and depth of media coverage regarding the Gene Technology Bill,' says Lisa Er, author of a petition to 'halt the progress of the Gene Technology Bill and instead set up a Commission of Inquiry into the health and safety of people and the environment on behalf of citizens, to allow time for wider community and stakeholder consultation.' Key Concerns: Environmental Risks: The Bill paves the way for the release of genetically modified organisms (GMOs) into New Zealand's unique ecosystems, risking irreversible impacts on native species, biodiversity, crops, and the country's global clean, green brand. Lack of Public Consultation: The Government has failed to meaningfully consult with Māori, scientists, and the wider public, ignoring Treaty of Waitangi obligations and indigenous rights, community concerns about food safety, cultural values, and environmental protection. Threat to Export Markets: New Zealand's primary export markets, especially in Europe and Asia, have strict GM-free requirements. The Bill endangers market access and could jeopardize billions in export earnings. Undermining Precaution: The Bill abandons the precautionary principle that has underpinned New Zealand's cautious approach to gene technology, exposing the country to unknown long-term risks. Ignoring International Best Practice: Leading nations are strengthening, not weakening, their oversight of gene technologies in response to new scientific evidence and public concern. Insufficient Public Debate: The bill has generated over 1,500 public submissions, reflecting deep divisions and strong opinions across the country. The removal of labelling GE is of considerable public concern. Why has the minimal media coverage largely focused on official statements and the potential benefits, with little attention paid to the risks, opposition viewpoints, or the broader societal debate that is unfolding in submissions and community discussions? Risk Oversight and Regulatory Gaps: the bill will open the door to unintended consequences, including ecosystem disruption, cross-contamination of crops, and unclear long-term health effects Transparency and Accountability: Some have questioned whether the bill is being rushed or if consultation has been adequate, particularly given the timing of the public submission period over the summer holidays Media outlets have an essential role in holding lawmakers accountable and ensuring transparency in the legislative process, and these risks deserve deeper journalistic investigation and public explanation. A Call to Action for the Media: We urge New Zealand's journalists and editors to fulfil their democratic duty by: – Investigating the full range of concerns about the Gene Technology Bill, including those raised in public submissions. – Highlighting the ethical, cultural, and environmental questions that remain unresolved. – Providing balanced, evidence-based coverage that empowers New Zealanders to make informed decisions about the future of gene technology in their country. 'The Gene Technology Bill represents a generational shift in New Zealand's approach to biotechnology', says Er. 'The public deserves robust, critical journalism that examines not only the promises but also the very real perils of this legislation.' Lisa Er, founder of Lisa's Hummus Issued in the public interest to encourage transparent, balanced, and investigative reporting on a matter of national importance Petition with over 4,000 signatures Petition request: That the House of Representatives halt the progress of the Gene Technology Bill and instead set up a Commission of Inquiry into the health and safety of people and the environment on behalf of citizens, to allow time for wider community and stakeholder consultation. Petition reason: I consider the Gene Technology Bill has failed to follow sound and fair processes by not consulting enough with the public and other stakeholders. I believe there is inadequate consideration of Te Tiriti obligations, and insufficient requirements to protect people and the environment from the risks of GE contamination. A range of gene editing techniques would be excluded from regulation. This would mean GE products would enter the environment and food supply untested, unregistered and unlabeled.